Dr Thomas Paul Alderson, MD in Sulphur, LA - Urology

Dr Thomas Paul Alderson, MD is a Urology physician based in Sulphur, Louisiana. Dr Thomas Paul Alderson is licensed to practice in Louisiana (license number 07139R) and his current practice location is 1327 Stelly Lane, Suite 2, Sulphur, Louisiana. He can be reached at his office (for appointments etc.) via phone at (337) 528-7898.

NPI number for Dr Thomas Paul Alderson is 1477544815 and his current mailing address is Po Box 5009, Brentwood, Tennessee. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1477544815.

Contact Information

	Dr Thomas Paul Alderson, MD
	1327 Stelly Lane, Suite 2, Sulphur, LA 70663
	(337) 528-7898
	(337) 528-7427

Physician's Profile

Full Name	Dr Thomas Paul Alderson
Gender	Male
Speciality	Urology
Location	1327 Stelly Lane, Sulphur, Louisiana
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1477544815
Provider Enumeration Date: 11/03/2005
Last Update Date: 01/04/2019

Medical Identifiers

Medical identifiers for Dr Thomas Paul Alderson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1477544815	NPI	-	NPPES
1900198	Other	LA	UNITED HEALTHCARE
340004858	Other	LA	RAILROAD MEDICARE
41480555490	Other	LA	BLUE CROSS BLUE SHIELD
LA6002281	Other	LA	TRICARE
1361674	Medicaid	LA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208800000X	Urology	07139R (Louisiana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Thomas Paul Alderson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Thomas Paul Alderson, MD Po Box 5009, Brentwood, TN 37024-5009 Ph: (615) 221-3642	Dr Thomas Paul Alderson, MD 1327 Stelly Lane, Suite 2, Sulphur, LA 70663 Ph: (337) 528-7898

News Archive

First Edition: June 9, 2014

Today's headlines include reports about efforts on the state level and within the health care system to address health care costs and advance other system reforms.

European approval of Pegasys for the treatment of chronic hepatitis B

The approval is granted for both types of the disease – HBeAg-positive and HBeAg-negative chronic hepatitis B. Pegasys offers the hope of a treatment-free life for thousands of people with chronic hepatitis B as this innovative drug has been shown to achieve lasting remission for a significant proportion of patients.

Cancer survival rates improving

Survival rates for cancers of the bowel, breast, lung and ovary that were diagnosed between 1995 and 2007 were compared between Australia, Canada, Denmark, Norway, Sweden and the UK. Overall, survival rates improved in all six countries. However, survival was found to be "persistently lower" in Denmark, England, Northern Ireland and Wales. This was particularly the case after the first year of diagnosis and for patients aged 65 and over. In UK cancer survival rates have improved significantly. Breast cancer survival at five years, for example, increased from 74.8% in 1995-9, to 81.6% in 2005-7. Despite this, the UK still has the lowest breast cancer survival rate at five years.

New journal focuses on therapeutic hypothermia and its applications in cardiology and neurotrauma

Therapeutic Hypothermia, a new online open access peer-reviewed journal, will focus on medical treatment which lowers a patient's body temperature to help reduce the risk of ischemic injury to tissues following a period of insufficient blood flow.

COVID-19 may trigger hyperglycemia by disrupting key metabolic signals to cause severe disease

COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia, according to a new study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Dr Thomas Paul Alderson, MD - Urology in Sulphur, LA